Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag The FDA is removing black box warnings from menopause hormone therapies for women under 60 or within 10 years of menopause, citing updated evidence of low risk.

flag The FDA is removing black box warnings from menopause hormone therapies, citing updated science showing risks like blood clots and heart issues are minimal for women under 60 or within 10 years of menopause. flag The change, effective by mid-2026, reflects reanalysis of older studies and recognizes that transdermal forms (patches, gels) carry lower risks than oral pills. flag Topical vaginal estrogen, previously mislabeled, is also exempt. flag The move aims to reduce fear-driven avoidance and support personalized treatment based on age, timing, and health history.

7 Articles

Further Reading